Related Experiment Videos
Behavioral and neurochemical changes produced by postnatal pretreatments with methamphetamine in rats
Insights
Postnatal methamphetamine (MAP) exposure in rats impairs catecholaminergic neuron development, leading to long-lasting behavioral changes and altered dopamine and noradrenaline signaling in the mature brain.
Area of Science:
- Neuroscience
- Developmental Toxicology
- Pharmacology
Background:
- Methamphetamine (MAP) is a potent psychostimulant with known neurotoxic effects.
- Early-life exposure to drugs of abuse can disrupt normal brain development and lead to long-term consequences.
Purpose of the Study:
- To investigate the long-term effects of postnatal methamphetamine (MAP) exposure on behavioral outcomes and neurochemical changes in Wistar rats.
- To examine the impact of MAP on dopamine and noradrenaline systems in the mature rat brain.
Main Methods:
- Male Wistar rat neonates received daily subcutaneous injections of MAP (1-4 mg/kg) from postnatal days 6-12.
- Behavioral testing, including avoidance learning and locomotor activity, was conducted from day 60.
- Neurotransmitter receptor binding (3H-spiperone, 3H-WB4101) and catecholamine levels (dopamine, noradrenaline, and metabolites) were measured in brain regions of adult rats.
Main Results:
- Postnatal MAP exposure did not significantly alter body weight, gross behaviors, or initial avoidance learning.
- MAP-pretreated rats showed increased locomotor activity in response to MAP and apomorphine.
- Significant alterations in dopamine and noradrenaline levels and their metabolites were observed in the brains of MAP-pretreated rats.
- Decreased Bmax and Kd values for 3H-spiperone binding in the striatum and 3H-WB4101 binding in the cortex and hippocampus were noted.
Conclusions:
- Postnatal MAP exposure induces lasting behavioral modifications and neurochemical deficits.
- These findings suggest impaired development of catecholaminergic neurons following early-life methamphetamine exposure.
- The study highlights the vulnerability of the developing brain to psychostimulant-induced neurotoxicity.
Abstract:
Male neonates of Wistar strain rats were given s.c. 1-4 mg/kg/day of methamphetamine (MAP) for 7 successive days from days 6 to 12 after birth. The acquisition processes of the discriminative lever-press avoidance response were investigated from day 60 after birth. Effects of the postnatal pretreatments with MAP on saturation constants for specific bindings of 3H-spiperone (SPP) and 3H-WB4101, respectively, in 8 brain regions were also investigated at 100-120 days after birth. In addition, dopamine, noradrenaline and the levels of their metabolites were measured in the brain. No significant difference was detected in body weight, gross behaviors and avoidance learning between saline- and MAP-pretreated groups. However, effects of MAP and apomorphine on the locomotor activity significantly increased in the MAP-pretreated group. Significant decreases in Bmax and Kd values of 3H-SPP binding sites in the striatum were detected in the MAP-pretreated group, while significant decreases in Bmax values of 3H-WB4101 binding sites in the cortex and hippocampus as well as those in Kd values in the hippocampus were found in the treated group. Dopamine and noradrenaline levels significantly decreased in the MAP-pretreated group, but on the contrary, their metabolites levels significantly increased. These results suggest that postnatal pretreatments with MAP produce long-lasting behavioral changes associated with an impaired development of catecholaminergic neurons in the rat brain after maturity.